Taiwan FDA registration e17465a1de1e3ea8b9fdcb68e8ceb217
“BIOTRONIK”Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System
TW: “百多力”鎂瑪斯西羅莫司冠狀動脈鎂金屬全吸收式支架系統
Taiwan·Risk Class 3·MD·BIOTRONIK AG·Registered Oct 02, 2018 – Oct 02, 2028ActiveRegistration details
- Analysis ID
- e17465a1de1e3ea8b9fdcb68e8ceb217
- License Form
- Ministry of Health Medical Device Import No. 030827
- Customs Code
- DHA05603082700
Company information
- Manufacturer
- BIOTRONIK AG
- Manufacturer Country
- Switzerland
- Authorized Representative
- BIOTRONIK TAIWAN LIMITED
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imports outside the borders;; Safety monitoring
Dates and status
- Registration Date
- Oct 02, 2018
- Expiry Date
- Oct 02, 2028
About this record
Access comprehensive regulatory information for “BIOTRONIK”Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e17465a1de1e3ea8b9fdcb68e8ceb217 and manufactured by BIOTRONIK AG. The authorized representative in Taiwan is BIOTRONIK TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices